BridgeBio Pharma, Inc. (BBIO) Discusses Optimistic Section III Outcomes for Encaleret in ADH1 CALIBRATE Research - Slideshow
BridgeBio Pharma, Inc. (BBIO) Discusses Optimistic Section III Outcomes for Encaleret in ADH1 CALIBRATE Research – Slideshow





















